ArticleFrontiers in oncology2026
Case Report: Case studies evaluating anti-HER2 therapy as a tumor-agnostic strategy in rare malignancies.
Piyanoot Jitthiang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it